Thierry Mauvernay
President, Delegate of the Board, Debiopharm International SA at Debiopharm Innovation Fund
About
President of Après-demain, the parent holding company of Debiopharm, and chairman of the investment committee of the Debiopharm Innovation Fund. He previously worked as an entrepreneur in the international cosmetics industry and holds a Master of Science in Economics and Marketing and an MBA.
Colleagues at Debiopharm Innovation Fund
Angela Zubel
Chief Development Officer, Research & Development at Debiopharm Innovation Fund
Bertrand Ducrey
Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund
Cedric Odje
Investment Associate at Debiopharm Innovation Fund
Frédéric Lévy
Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund
Marc Cikes
Managing Director at Debiopharm Innovation Fund
Nicolas Favre
Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund
Nicolas Stalder
Senior Investment Associate at Debiopharm Innovation Fund
Pierre Jullian
Chief Finance Officer, Finance, HR, IT & Administration at Debiopharm Innovation Fund